Suchergebnisse - "Palmieri, Salvatore"

PubPharm (10)

1

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma : a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials

enthalten in: Haematologica | 2024

von Gentile, M. | Vigna, E. | Palmieri, S. | +44

2

Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders : A Multicenter Real-Life Experience

enthalten in: Targeted oncology | 2023

von De Novellis, D. | Fontana, R. | Palmieri, S. | +30

3

Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients : italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials

enthalten in: Hematological oncology | 2022

von Martino, E. | Conticello, C. | Zamagni, E. | +30

4

Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma : Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials

enthalten in: Hematological oncology | 2022

von Bruzzese, A. | Derudas, D. | Galli, M. | +57

5

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2022

von Bertamini, L. | Oliva, S. | Rota-Scalabrini, D. | +26

CommentIn: J Clin Oncol. 2022 Sep 20;40(27):3099-3102. - PMID 35759726

6

Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma : Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials

enthalten in: Haematologica | 2021

von Gentile, M. | Specchia, G. | Derudas, D. | +53

7

KRD (carfilzomib and lenalidomide plus dexamethasone) for the treatment of relapsed or refractory multiple myeloma in the real-life : a retrospective survey in 123 patients

enthalten in: Annals of hematology | 2020

von Palmieri, S. | Rocco, S. | Vitagliano, O. | +17

8

Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients : an Italian multicenter retrospective study

enthalten in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation | 2014

von Martino, M. | Montanari, M. | Ferrara, F. | +16

9

Low-dose rituximab in adult patients with primary immune thrombocytopenia

enthalten in: European journal of haematology | 2010

von Zaja, F. | Vianelli, N. | Volpetti, S. | +10

10

ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia

enthalten in: Blood | 2007

von Gregorj, C. | Ricciardi, M. | Petrucci, M. | +26

1
[1]